cbdMD (YCBD) EPS (Weighted Average and Diluted) (2017 - 2024)
Historic EPS (Weighted Average and Diluted) for cbdMD (YCBD) over the last 8 years, with Q2 2024 value amounting to -$0.15.
- cbdMD's EPS (Weighted Average and Diluted) rose 8706.9% to -$0.15 in Q2 2024 from the same period last year, while for Jun 2024 it was -$4.4, marking a year-over-year decrease of 2394.37%. This contributed to the annual value of -$0.47 for FY2021, which is 27438.23% down from last year.
- According to the latest figures from Q2 2024, cbdMD's EPS (Weighted Average and Diluted) is -$0.15, which was up 8706.9% from -$1.35 recorded in Q1 2024.
- In the past 5 years, cbdMD's EPS (Weighted Average and Diluted) registered a high of $0.4 during Q1 2020, and its lowest value of -$1.74 during Q1 2023.
- Over the past 5 years, cbdMD's median EPS (Weighted Average and Diluted) value was -$0.18 (recorded in 2020), while the average stood at -$0.41.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 11278.44% in 2020, then plummeted by 285087.87% in 2022.
- Over the past 5 years, cbdMD's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.18 in 2020, then tumbled by 93.7% to -$0.35 in 2021, then plummeted by 57.8% to -$0.55 in 2022, then plummeted by 110.84% to -$1.16 in 2023, then skyrocketed by 87.07% to -$0.15 in 2024.
- Its EPS (Weighted Average and Diluted) stands at -$0.15 for Q2 2024, versus -$1.35 for Q1 2024 and -$1.16 for Q2 2023.